Friday, January 6, 2017

Vir Biotechnology Raises More Than $150M To Fight Infectious Disease

San Francisco-based Vir Biotechnology, a new startup which says it is developing cures, treatments, and preventions for challenging infectious diseases, said today that it has raised $150M in funding, and launched the startup. The company is led by former Biogen CEO George Scangos. The funding was led by ARCH Venture Partners and the Bill & Melinda Gates Foundation, and also included un-named sovereign wealth funds, public mutual funds and individuals and family offices.